Dan Roden
Faculty Member
Last active: 2/8/2016

  1. Increased late sodium current contributes to long QT-related arrhythmia susceptibility in female mice. Lowe JS, Stroud DM, Yang T, Hall L, Atack TC, Roden DM (2012) Cardiovasc Res 95(3): 300-7
    › Primary publication · 22562703 (PubMed) · PMC3633400 (PubMed Central)
  2. High density GWAS for LDL cholesterol in African Americans using electronic medical records reveals a strong protective variant in APOE. Rasmussen-Torvik LJ, Pacheco JA, Wilke RA, Thompson WK, Ritchie MD, Kho AN, Muthalagu A, Hayes MG, Armstrong LL, Scheftner DA, Wilkins JT, Zuvich RL, Crosslin D, Roden DM, Denny JC, Jarvik GP, Carlson CS, Kullo IJ, Bielinski SJ, McCarty CA, Li R, Manolio TA, Crawford DC, Chisholm RL (2012) Clin Transl Sci 5(5): 394-9
    › Primary publication · 23067351 (PubMed) · PMC3521536 (PubMed Central)
  3. Genetics and cardiovascular disease: a policy statement from the American Heart Association. Ashley EA, Hershberger RE, Caleshu C, Ellinor PT, Garcia JG, Herrington DM, Ho CY, Johnson JA, Kittner SJ, Macrae CA, Mudd-Martin G, Rader DJ, Roden DM, Scholes D, Sellke FW, Towbin JA, Van Eyk J, Worrall BB, American Heart Association Advocacy Coordinating Committee (2012) Circulation 126(1): 142-57
    › Primary publication · 22645291 (PubMed) · PMC3721666 (PubMed Central)
  4. Genetic determinants of response to cardiovascular drugs. Wells QS, Delaney JT, Roden DM (2012) Curr Opin Cardiol 27(3): 253-61
    › Primary publication · 22382501 (PubMed) · PMC3874723 (PubMed Central)
  5. Electronic medical records as a tool in clinical pharmacology: opportunities and challenges. Roden DM, Xu H, Denny JC, Wilke RA (2012) Clin Pharmacol Ther 91(6): 1083-86
    › Primary publication · 22534870 (PubMed) · PMC3819803 (PubMed Central)
  6. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. Jamshidi Y, Nolte IM, Dalageorgou C, Zheng D, Johnson T, Bastiaenen R, Ruddy S, Talbott D, Norris KJ, Snieder H, George AL, Marshall V, Shakir S, Kannankeril PJ, Munroe PB, Camm AJ, Jeffery S, Roden DM, Behr ER (2012) J Am Coll Cardiol 60(9): 841-50
    › Primary publication · 22682551 (PubMed) · PMC3753216 (PubMed Central)
  7. Clopidogrel: a case for indication-specific pharmacogenetics. Johnson JA, Roden DM, Lesko LJ, Ashley E, Klein TE, Shuldiner AR (2012) Clin Pharmacol Ther 91(5): 774-6
    › Primary publication · 22513313 (PubMed) · PMC3382015 (PubMed Central)
  8. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. Ritchie MD, Rowan S, Kucera G, Stubblefield T, Blair M, Carter S, Roden DM, Darbar D (2012) J Am Coll Cardiol 60(13): 1173-81
    › Primary publication · 22818067 (PubMed) · PMC3448817 (PubMed Central)
  9. Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans. Delaney JT, Jeff JM, Brown NJ, Pretorius M, Okafor HE, Darbar D, Roden DM, Crawford DC (2012) PLoS One 7(2): e32338
    › Primary publication · 22384221 (PubMed) · PMC3285683 (PubMed Central)
  10. Cardiovascular pharmacogenomics: current status and future directions-report of a national heart, lung, and blood institute working group. Musunuru K, Roden DM, Boineau R, Bristow MR, McCaffrey TA, Newton-Cheh C, Paltoo DN, Rosenberg Y, Wohlgemuth JG, Zineh I, Hasan AA (2012) J Am Heart Assoc 1(2): e000554
    › Primary publication · 23130127 (PubMed) · PMC3487365 (PubMed Central)